Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.001 | 0 | 0.5 | |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0053 | 0.7477 | 0.7477 |
Echinococcus granulosus | GPCR family 2 | 0.0017 | 0.1106 | 0.1106 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.1106 | 0.1106 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0067 | 1 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0036 | 0.4528 | 0.4528 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.1106 | 0.1106 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0017 | 0.1106 | 0.1106 |
Loa Loa (eye worm) | TAR-binding protein | 0.0067 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.6497 | 0.6497 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.1106 | 0.1106 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0017 | 0.1106 | 0.1106 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.6497 | 0.6497 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0053 | 0.7477 | 0.7477 |
Brugia malayi | TAR-binding protein | 0.0067 | 1 | 1 |
Echinococcus multilocularis | GPCR, family 2 | 0.0017 | 0.1106 | 0.1106 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.6497 | 0.6497 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0047 | 0.6497 | 0.6497 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0047 | 0.6497 | 0.6497 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.001 | 0 | 0.5 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0017 | 0.1106 | 0.1106 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0047 | 0.6497 | 0.6497 |
Loa Loa (eye worm) | hypothetical protein | 0.0036 | 0.4528 | 0.4528 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0017 | 0.1106 | 0.1106 |
Loa Loa (eye worm) | RNA binding protein | 0.0067 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.7477 | 0.7477 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.1106 | 0.1106 |
Echinococcus granulosus | tar DNA binding protein | 0.0067 | 1 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0067 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 1 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0067 | 1 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0047 | 0.6497 | 0.6497 |
Schistosoma mansoni | hypothetical protein | 0.0036 | 0.4528 | 0.4528 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.6497 | 0.6497 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0047 | 0.6497 | 0.6497 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 1 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0017 | 0.1106 | 0.1106 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0017 | 0.1106 | 0.1106 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0017 | 0.1106 | 0.1106 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 1 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0053 | 0.7477 | 0.7477 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0017 | 0.1106 | 0.1106 |
Onchocerca volvulus | Bile acid receptor homolog | 0.001 | 0 | 0.5 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.001 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.